Neonatal group B streptococcus disease in developing countries: are we ready to deploy a vaccine?

about

Carriage and serotype distribution of Streptococcus agalactiae in third trimester pregnancy in southern Ghana.Diagnostics for neonatal sepsis: Current approaches and future directions.Whole genome shotgun sequencing of Indian strains of Streptococcus agalactiae.

P2860

Q33921927-88292974-AD03-42AA-919D-482E858760A6 Q38675657-03341D0C-417A-44AC-AE07-89D4AF6BCBEB Q42269212-09882F92-75D4-4C5E-9991-8C9DC833AE87

P2860

Neonatal group B streptococcus disease in developing countries: are we ready to deploy a vaccine?

Item

http://www.wikidata.org/entity/Q40625732

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Neonatal group B streptococcus ...... we ready to deploy a vaccine?

@en

type

Item

label

Neonatal group B streptococcus ...... we ready to deploy a vaccine?

@en

prefLabel

Neonatal group B streptococcus ...... we ready to deploy a vaccine?

@en

P1476

Neonatal group B streptococcus ...... we ready to deploy a vaccine?

@en

P2093

Shirley F Delair

http://www.w3.org/2001/XMLSchema#string

Stephen K Obaro

http://www.w3.org/2001/XMLSchema#string

P2860

An overview of global GBS epidemiology

Population-based incidence and etiology of community-acquired neonatal bacteremia in Mirzapur, Bangladesh: an observational study.

Etiology of bacteremia in young infants in six countries.

Increased risk for group B Streptococcus sepsis in young infants exposed to HIV, Soweto, South Africa, 2004-2008(1).

Changing patterns in neonatal Escherichia coli sepsis and ampicillin resistance in the era of intrapartum antibiotic prophylaxis.

Invasive group B streptococcal infection in infants, Malawi

Pathogens associated with sepsis in newborns and young infants in developing countries.

Variation in reported neonatal group B streptococcal disease incidence in developing countries.

Epidemiology of Group B Streptococcus in developing countries.

Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants.

P304

1401-1403

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14760584.2015.1077121

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Pui-Ying Iroh Tam

P577

2015-08-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

280909182

http://www.w3.org/2001/XMLSchema#string

P698

26289974

http://www.w3.org/2001/XMLSchema#string

Neonatal group B streptococcus disease in developing countries: are we ready to deploy a vaccine?

about

P2860

P2860

Neonatal group B streptococcus disease in developing countries: are we ready to deploy a vaccine?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698